Extended Stability of Reconstituted Lyophilized Erwinia L-asparaginase in Vials

Background/Aim: L-Asparaginase (L-ASNase) is used as a tumor-inhibitory drug on paediatric acute lymphoblastic leukemia (ALL). ERW-ASNase is commercialised as a lyophilized powder stable only for 8 hours once reconstituted and, consequently, the leftover is usually discarded. The aim of this study w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:In Vivo
Hlavní autoři: VIÑA-ROMERO, MICAELA M, RAMOS-DIAZ, RUTH, MOURANI-PADRON, IVETTE, GONZALEZ-MENDEZ, HECTOR, GONZALEZ-CRUZ, MACARENA, NAZCO-CASARIEGO, GLORIA, MERINO-ALONSO, JAVIER JULIA F., DIAZ-VERA, JESICA, GUTIÉRREZ-NICOLÁS, FERNANDO
Médium: Artigo
Jazyk:Inglês
Vydáno: International Institute of Anticancer Research 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7652457/
https://ncbi.nlm.nih.gov/pubmed/32871767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12055
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky